We next investigated whether the ablation of Bscl2 in hepatocytes in the background of lipodystrophy would lead to the development of hepatic steatosis that is commonly observed in the global Bscl2 knockout mouse models. The gene discussed is BSCL2; the disease is lipodystrophy.